Autologous Hematopoietic Stem Cell Transplant Slows Disability Progression in MS
WEDNESDAY, Dec. 28, 2022 -- For patients with active secondary progressive multiple sclerosis (SPMS), autologous hematopoietic stem cell transplantation (AHSCT) is associated with a slowing of disease progression compared with other...
Read more »